About this event
In this webinar, Prof Lorenzen and Prof Zaanan will be discussing the new evidence on 3L mGC applied to daily practice.
The presentation will be followed by live interactive clinical cases and a dedicated Q&A session during which you will be able to directly send your questions to the speakers.
Hosted by
-
Guest speaker
Prof Aziz Zaanan Associate Professor @ Hôpital Européen Georges PompidouG
Prof Zaanan's research interests focus on the genetic alterations in digestive tumors and their implications for prognosis and response to treatment. He is chairman of the French Gastrointestinal Oncologist Association, and a member of the ESMO “Gastrointestinal tumors” faculty.
-
Guest speaker
Prof Sylvie Lorenzen Head of the Phase I Unit @ University Hospital rechts der Isar, Technical University of Munich, GermanyG
Prof Lorenzen’s research interests include clinical research in medical oncology, response evaluation in solid tumor therapy and multimodality treatment of gastrointestinal cancer. She is head of the gastroesophageal working group of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
BRIDGE
BRIDGE is an initiative by Servier that connects health care professionals worldwide to share knowledge on gastrointestinal (GI) cancers and their management.
